Hims & Hers Health Makes Australia, Japan Foray With $1.15 Billion Eucalyptus Acquisition
Hims & Hers Health, Inc. (HIMS) announced on Thursday that it has signed a definitive agreement to acquire Eucalyptus in a deal valued at up to $1.15 billion.
The transaction, expected to close in mid-2026, will strengthen the company's ability to deliver personalized digital healthcare internationally, Hims & Hers said.
Upon completion, Hims & Hers plans to expand into Australia and Japan and deepen its presence in the UK, Germany, and Canada. Eucalyptus CEO Tim Doyle will join Hims & Hers as senior vice president (SVP) of International, and Eucalyptus' brands will gradually transition to the Hims & Hers platform.
HIMS shares were trading 3.4% higher in premarket on Thursday.
Get updates to this developing story on Stocktwits.
For updates and corrections, email newsroom[at]stocktwits[dot]com.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment